New method of genome editing derived from CRISPR/Cas9

Progress in Biochemistry and Biophysics

Volumn 40, Issue 8, 2013, Pages 691-702

  Fang, Rui ^a   Chang, Fei ^a   Sun, Zhao Lin ^a   Li, Ning ^a   Meng, Qing Yong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

CRISPR Cas9; Engineered endonuclease; Gene targeting; Genome editing technology

Indexed keywords

EID: 84887930166     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2013.00215     Document Type: Review

References (85)

1. Kim Y G, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA, 1996, 93(3): 1156-1160 (Pubitemid 26052857)
2. Urnov F D, Rebar E J, Holmes M C, et al. Genome editing with engineered zinc finger nucleases. Nat Rev Genet, 2010, 11(9): 636-646
3. Perez E E, Wang J, Miller J C, et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol, 2008, 26(7): 808-816 (Pubitemid 351961450)
4. Moscou M J, Bogdanove A J. A simple cipher governs DNA recognition by TAL effectors. Science, 2009, 326(5959): 1501
5. Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 2009, 326(5959): 1509-1512
6. Boch J, Bonas U. Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol, 2010, 48: 419-436
7. Li T, Huang S, Zhao X, et al. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic acids Res, 2011, 39(14): 6315-6325
8. Joung J K, Sander J D. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol, 2013, 14 (1): 49-55
9. Breakthrough of the year. The runners-up. Science, 2012, 338(6114): 1525-1532
10. Mussolino C, Cathomen T. RNA guides genome engineering. Nat Biotechnol, 2013, 31(3): 208-209
11. Ishino Y, Shinagawa H, Makino K, et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol, 1987, 169(12): 5429-5433 (Pubitemid 18017837)
12. Jansen R, van Embden J D, Gaastra W, et al. Identification of a novel family of sequence repeats among prokaryotes. Omics: a Journal of Integrative Biology, 2002, 6(1): 23-33
13. Mojica F J, Ferrer C, Juez G, et al. Long stretches of short tandem repeats are present in the largest replicons of the archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol, 1995, 17(1): 85-93
14. Jansen R, Embden J D, Gaastra W, et al. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol, 2002, 43(6): 1565-1575 (Pubitemid 34595547)
15. Bolotin A, Quinquis B, Sorokin A, et al. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology, 2005, 151 (Pt 8): 2551-2561 (Pubitemid 41149778)
16. Mojica F J, Diez-Villasenor C, Garcia-Martinez J, et al. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol, 2005, 60(2): 174-182 (Pubitemid 40568857)
17. Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology, 2005, 151(Pt 3): 653-663 (Pubitemid 40425001)
18. Makarova K S, Grishin N V, Shabalina S A, et al. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct, 2006, 1: 7
19. Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007, 315(5819): 1709-1712 (Pubitemid 46515624)
20. Marraffini L A, Sontheimer E J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science, 2008, 322(5909): 1843-1845
21. Grissa I, Vergnaud G, Pourcel C. CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucl Acids Res, 2007, 35(Web Server issue): W52-57
22. Rousseau C, Gonnet M, Le Romancer M, et al. CRISPI: a CRISPR interactive database. Bioinformatics, 2009, 25(24): 3317-3318
23. Grissa I, Vergnaud G, Pourcel C. The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics, 2007, 8: 172
24. Godde J S, Bickerton A. The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes. J Mol Evol, 2006, 62(6):718-729 (Pubitemid 43847221)
25. Deveau H, Garneau JE, Moineau S. CRISPR/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol, 2010, 64: 475-493
26. Kunin V, Sorek R, Hugenholtz P. Evolutionary conservation of sequence and secondary structures in CRISPR repeats. Genome Biol, 2007, 8(4): R61
27. Makarova K S, Aravind L, Grishin N V, et al. A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis. Nucleic Acids Res, 2002, 30(2):482-496 (Pubitemid 34679610)
28. Heidelberg J F, Nelson W C, Schoenfeld T, et al. Germ warfare in a microbial mat community: CRISPRs provide insights into the co-evoution of host and viral genomes. PIoS One, 2009, 4(1): e4169
29. Horvath P, Coute-Monvoisin A C, Romero D A, et al. Comparative analysis of CRISPR loci in lactic acid bacteria genomes. Int J Food Microbiol, 2009, 131(1): 62-70
30. Haft D H, Selengut J, Mongodin E F, et al. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLOS Comput Biol, 2005, 1(6): e60
31. Sinkunas T, Gasiunas G, Fremaux C, et al. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J, 2011, 30(7): 1335-1342
32. Haurwitz R E, Jinek M, Wiedenheft B, et al. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science, 2010, 329(5997): 1355-1358
33. Wiedenheft B, Zhou K, Jinek M, et al. Structural basis for DNase activity of a conserved protein implicated in CRISPR-mediated genome defense. Structure, 2009, 17(6): 904-912
34. Wiedenheft B, van Duijn E, Bultema J B, et al. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci USA, 2011, 108(25): 10092-10097
35. Garneau J E, Dupuis M E, Villion M, et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 2010, 468(7320): 67-71
36. Deltcheva E, Chylinski K, Sharma C M, et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 2011, 471(7340): 602-607
37. Anantharaman V, Iyer L M, Aravind L. Presence of a classical RRM-fold palm domain in Thg1-type 3′- 5′nucleic acid polymerases and the origin of the GGDEF and CRISPR polymerase domains. Biol Direct, 2010, 5: 43
38. Hale C R, Zhao P, Olson S, et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell, 2009, 139(5): 945-956
39. Terns M P, Teras R M. CRISPR-based adaptive immune systems. Curr Opin Microbiol, 2011, 14(3): 321-327
40. Portillo M C, Gonzalez J M. CRISPR elements in the Thermococcales: evidence for associated horizontal gene transfer in Pyococcus furiosus. J Appl Genet, 2009, 50(4):421-430
41. Mojica F J, Diez-Villasenor C, Garcia-Martinez J, et al. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiol, 2009, 155(Pt 3): 733-740
42. Beloglazova N, Brown G, Zimmerman M D, et al. A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats. J Biol Chem, 2008, 283(29): 20361-20371
43. Brouns S J, Jore M M, Lundgren M, et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 2008, 321(5891): 960-964
44. Pougach K, Semenova E, Bogdanova E, et al. Transcription, processing and function of CRISPR cassettes in Escherichia coli. Mol Microbiol, 2010, 77(6): 1367-1379
45. Pul U, Wurm R, Arslan Z, et al. Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS. Mol Microbiol, 2010, 75(6): 1495-1512
46. Agari Y, Sakamoto K, Tamakoshi M, et al. Transcription profile of Thermus thermophilus CRISPR systems after phage infection. J Mol Biol, 2010, 395(2): 270-281
47. Hale C, Kleppe K, Terns R M, et al. Prokaryotic silencing (psi) RNAs in Pyrococcus furiosus. Rna, 2008,14(12): 2572-2579
48. Lillestol R K, Shah S A, Brugger K, et al. CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and dynamic properties. Molecular Microbiology, 2009,72(1): 259-272
49. Phok K, Moisan A, Rinaldi D, et al. Identification of CRISPR and riboswitch related RNAs among novel noncoding RNAs of the euryarchaeon Pyrococcus abyssi. BMC Genomics, 2011, 12: 312
50. Lillestol R K, Redder P, Garrett R A, et al. A putative viral defence mechanism in archaeal cells. Archaea, 2006, 2(1): 59-72 (Pubitemid 44377988)
51. Shinkai A, Kira S, Nakagawa N, et al. Transcription activation mediated by a cyclic AMP receptor protein from Thermus thermophilus HB8. J Bacteriol, 2007, 189(10):3891-3901 (Pubitemid 46740187)
52. Deveau H, Barrangou R, Garneau J E, et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol, 2008, 190(4): 1390-1400 (Pubitemid 351215022)
53. Semenova E, Nagornykh M, Pyatnitskiy M, et al. Analysis of CRISPR system function in plant pathogen Xanthomonas oryzae. FEMS Microbiology Letters, 2009, 296(1): 110-116
54. Marraffini L A, Sontheimer E J. Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature, 2010, 463(7280): 568-571
55. Barrangou R, Horvath P. CRISPR: new horizons in phage resistance and strain identification. Annu Rev Food Sci Technol, 2012, 3: 143-162
56. Hwang W Y, Fu Y, Reyon D, et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol, 2013, 31(3): 227-229
57. Mali P, Yang L, Esvelt K M, et al. RNA-guided human genome engineering via Cas9. Science, 2013, 339(6121): 823-826
58. Cong L, Ran F A, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339(6121): 819-823
59. Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012, 337(6096): 816-821
60. Gasiunas G, Barrangou R, Horvath P, et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA, 2012, 109(39): E2579-2586
61. Chang N, Sun C, Gao L, et al. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res, 2013, 23(4):465-472
62. Kim Y, Kweon J, Kim A, et al. A library of TAL effector nucleases spanning the human genome. Nat Biotechnol, 2013, 31(3):251-258
63. Bultmann S, Morbitzer R, Schmidt C S, et al. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res, 2012, 40(12): 5368-5377
64. Chen S, Oikonomou G, Chiu C N, et al. A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly. Nucleic Acids Res, 2013, 41(4): 2769-2778
65. Shen B, Zhang J, Wu H, et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res, 2013, 23 (5): 720-723
66. Ding Q, Regan S N, Xia Y, et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell, 2013, 12(4): 393-394
67. Liu G H, Suzuki K, Qu J, et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell, 2011, 8(6): 688-694
68. Wang Y, Zheng C G, Jiang Y, et al. Genetic correction of beta-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res, 2012, 22(4): 637-648
69. Kazuki Y, Hiratsuka M, Takiguchi M, et al. Complete genetic correction of ips cells from Duchenne muscular dystrophy. Molecular therapy: the journal of the American Society of Gene Therapy, 2010, 18(2): 386-393
70. Sun N, Longaker M T, Wu J C. Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle, 2010, 9(5): 880-885
71. Carlson D F, Tan W, Lillico S G, et al. Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci USA, 2012, 109(43): 17382-17387
72. Yu S, Luo J, Song Z, et al. Highly efficient modification of beta-lactoglobulin (BLG) gene via zinc-finger nucleases in cattle. Cell Res, 2011, 21(11): 1638-1640
73. Yang D, Yang H, Li W, et al. Generation of PPARgamma mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning. Cell Res, 2011, 21(6): 979-982
74. Hauschild J, Petersen B, Santiago Y, et al. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci USA, 2011, 108(29): 12013-12017
75. Van Laere A S, Nguyen M, Braunschweig M, et al. A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature, 2003, 425(6960): 832-836 (Pubitemid 37351466)
76. Clop A, Marcq F, Takeda H, et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet, 2006, 38(7): 813-818 (Pubitemid 43980603)
77. Tan W S, Carlson D F, Walton M W, et al. Precision editing of large animal genomes. Adv Genet, 2012, 80: 37-97
78. Wang H, Yang H, Shivalila C S, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 2013
79. Miller J C, Tan S, Qiao G, et al. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol, 2011, 29(2): 143-148
80. Zhang F, Cong L, Lodato S, et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol, 2011, 29(2): 149-153
81. Morbitzer R, Romer P, Boch J, et al. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors. Proc Natl Acad Sci USA, 2010, 107(50): 21617-21622
82. Qi L S, Larson M H, Gilbert L A, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 2013, 152(5): 1173-1183
83. Koonin E V, Wolf Y I. Is evolution Darwinian or/and Lamarckian? Biol Direct, 2009, 4: 42
84. Sampson T R, Saroj S D, Llewellyn A C, et al. A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature, 2013, 497(7448): 254-257
85. Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science, 2010, 327(5962): 167-170